1.Cossart, Ye, Field, AM, Cant, B, Widdows, D, Parvovirus like particles in human sera. Lancet 1975; i: 72–3.
2.Anderson, MJ, Cohen, BJ, Human parvovirus B19 infections in United Kingdom 1984–1986. Lancet 1987; i: 738–9.
3.Courouce, AM, Ferchal, F, Morinet, F et al. , Human parvovirus infection in France. Lancet 1984; i: 160.
4.Naides, SJ, Erythema infectiosum (fifth disease) occurrence in Iowa. Am J Public Health 1988; 78: 1230–1.
5.Cohen, BJ, Human parvovirus B19 and Fifth disease. In: Mortimer, PP, ed. Public health virology: twelve reports. London: Public Health Laboratory Service, 1986: 130–43.
6.Plummer, FA, Hammond, GW, Forward, K et al. , An erythema infectiosum like illness caused by human parvovirus infection. N Engl J Med 1985; 313: 74–9.
7.Woolf, AD, Campion, GVChiswick, et al. , Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med. 1989; 149: 1153–6.
8.Pattison, JR, Jones, SE, Hodgson, J et al. , Parvovirus infections and hypoplastic crisis in sickle cell anaemia. Lancet 1981: i: 644–5.
9.Serjeant, GR, Topley, JM, Mason, K et al. , Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus like agent. Lancet 1981; ii: 595–7.
10.Chorba, T, Coccia, P, Holman, RC, The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease). J Infect Dis 1986; 154: 383–93.
11.Rao, KR, Patel, AR, Anderson, MJ, Jones, SE, Pattison, JR, Infection with parvovirus like virus and aplastic crisis in chronic haemolytic anaemia. Ann Intern Med 1983; 98: 230–2.
12.Koch, WC, Massey, G, Russell, CE, Adler, SP, Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J Pediatr 1990; 116: 355–9.
13.Kurtzman, GJ, Cohen, B, Meyers, P, Amunullah, A, Young, NS, Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukemia. Lancet 1988; ii: 1159–62.
14.Van Horn, DK, Mortimer, PP, Young, N, Hason, GR, Human parvovirus associated red cell aplasia in the absence of underlying haemolytic anaemia. Am J Pediatr Hematol Oncol 1986; 8: 235–9.
15.Anderson, LJ, Hurwitz, ES, Human parvovirus in pregnancy. Clin Perinatol 1988; 15: 273.
16.Hall, SM, Parvovirus B19 and pregnancy. Rev Medical Microbiol 1990; 1: 160–7.
17.Pillay, D, Patou, G, Hurt, S, Kibbler, CC, Griffiths, PD, Parvovirus B19 outbreak in a children's ward. Lancet 1992; 339: 107–9.
18.Bell, LM, Naides, SJ, Stoffman, P, Hodinka, RL, Plotkin, SA, Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Eng J Med 1989; 321: 485–91.
19.Anderson, MJ, Higgins, PG, Davis, LR, et al. Experimental parvoviral infection in humans. J Infect Dis 1985; 152: 257–65.
20.Communicable Disease Surveillance Centre. Trends in rubella and parvovirus B19 infections. Commun Dis Rep 1993; 3: 125.
21.Cohen, BJ, Mortimer, PP, Pereira, MS, Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg 1983; 91: 113–30.
22.Mori, J, Field, AM, Clewley, JP, Cohen, BJ, Dot blot hybridisation assay of B19 virus DNA in clinical specimens. J Clinical Microbiol 1989; 27: 459–64.
23.Centers for Disease Control. Risks associated with human parvovirus B19 infections. MMWR 1989; 38: 81–8. 93–7.
24.Koziol, DE, Kurtzman, G, Ayub, J, Young, NS, Henderson, DK, Nosocomial human parvovirus B19 infection: Lack of transmission from a chronically infected patient to hospital staff. Infect Cont Hosp Epidemiol 1992; 13: 343–8.
25.Goldmann, D, Larson, E, Hand-washing and nosocomial infections. N Engl J Med 1992; 327: 120–7.
26.Isaacs, D, Dickson, H, O'Callaghan, , Sheaves, R, Winter, A, Moxon, ER, Handwashing and cohorting in prevention of hospital acquired infections in respiratory syncytial virus. Arch Dis Child 1991; 66: 227–31.
27.Hall, CB, Douglas, RG Jr. Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99: 100–3.
28.Hall, CB, Douglas, RG Jr, Geiman, JM, Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 1980; 141: 98–102.